PEOPLE - Novel Diagnostics makes appointment:
This article was originally published in Clinica
Executive Summary
Infectious diseases and colorectal cancer early diagnosis company Novel Diagnostics (Bergen, Norway) has appointed board member Guido Guidetti as president, in which role he will oversee international marketing, licensing and business development strategies. In 26 years in the industry, he has advised and offered consultancy to J&J, Abbott, International Murex Technologies (including on its purchase by Abbott), Chiron and Apogent Technologies, among others.